✦ LIBER ✦

Over-expression of CCL3 MIP-1α in a blastoid mantle cell lymphoma with hypercalcemia

✍ Scribed by Norimichi Hattori; Tsuyoshi Nakamaki; Hirotsugu Ariizumi; Mayumi Homma; Toshiko Yamochi-Onizuka; Hidekazu Ota; Shigeru Tomoyasu

Book ID: 114794730
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 177 KB
Volume: 84
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.2009.01405.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression of MIP-3α/CCL20, a macrophage

Expression of MIP-3α/CCL20, a macrophage inflammatory protein in oral squamous cell carcinoma

✍ Yoshihiro Abiko; Michiko Nishimura; Kaoru Kusano; Keisuke Nakashima; Kazuhiko Ok 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 159 KB

RV1A and dsRNA highly induce a biphasic

RV1A and dsRNA highly induce a biphasic expression of MIP-3α/CCL20 in human bronchial epithelial cells (hBECs)

✍ Bellak, J.M.; Hanson, K.; Brockman-Schneider, R.A.; Dagher, H.; Gern, J.E. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 35 KB

Coexistence of BCL1/CCND1 and CMYC aberr

Coexistence of BCL1/CCND1 and CMYC aberrations in blastoid mantle cell lymphoma: a rare finding associated with very poor outcome

✍ L. Michaux; I. Wlodarska; I. Theate; M. Stul; J.-M. Scheiff; V. Deneys; A. Ferra 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 180 KB

Macrophage Inflammatory Protein-1 alpha

Macrophage Inflammatory Protein-1 alpha (MIP-1α) is over-expressed in a cohort of patients with myelodysplastic syndromes

✍ Despina Mavrogianni; Panagiotis Tsaftaridis; Evangelos Terpos; Argiris Symeonidi 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

Protein expression of B-cell lymphoma ge

Protein expression of B-cell lymphoma gene 6 (BCL-6) in invasive breast cancer is associated with cyclin D1 and hypoxia-inducible factor-1α (HIF-1α)

✍ Bos, Reinhard; Diest, Paul J van; Groep, Petra van der; Greijer, Astrid E; Herms 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 152 KB

Quantitative monitoring of cyclin D1 exp

Quantitative monitoring of cyclin D1 expression: A molecular marker for minimal residual disease monitoring and a predictor of the disease outcome in patients with mantle cell lymphoma

✍ Helena Brizova; Marketa Kalinova; Lenka Krskova; Marcela Mrhalova; Roman Kodet 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 235 KB

## Abstract In mantle cell lymphoma (MCL), minimal residual disease (MRD) is an indicator of the disease outcome. Quantitative methods used so far do not provide a suitable molecular marker in 30–70% patients with MCL (depending on the technique used). We tested cyclin D1 as a marker for quantitati